ArticleBlood advances2023

Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress.

Beatriz Gomez Solsona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.